دورية أكاديمية

The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition

التفاصيل البيبلوغرافية
العنوان: The Evolving Treatment Landscape of Advanced Renal Cell Carcinoma in Patients Progressing after VEGF Inhibition
المؤلفون: Barata, Pedro C., Ornstein, Moshe C., Garcia, Jorge A.
المصدر: Journal of Kidney Cancer and VHL; Vol. 4 No. 2 (2017): Journal of Kidney Cancer and VHL; 10-18 ; 2203-5826
بيانات النشر: Codon Publications
سنة النشر: 2017
المجموعة: Journal of Kidney Cancer and VHL (JKCVHL)
مصطلحات موضوعية: Advanced renal cell carcinoma, immunotherapy, mTOR inhibitors, PD-1/PD-L1, sequential therapy, VEGF inhibitors, Kidney Cancer, Oncology
الوصف: Despite significant changes in the therapeutic landscape of renal cell carcinoma, the majority of patients with metastatic disease eventually progress after first-line treatment with vascular endothelial growth factor receptors (VEGFR) tyrosine kinase inhibitor (TKI) therapy. Understanding existing data on subsequent therapies is crucial to define an optimal treatment sequence following first-line failure. This review examines the data supporting currently approved agents in this setting and provides a framework for decision-making regarding treatment sequencing beyond first-line therapy with VEGFR TKIs.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf; text/html; application/xml
اللغة: English
العلاقة: https://jkcvhl.com/index.php/jkcvhl/article/view/69/160Test; https://jkcvhl.com/index.php/jkcvhl/article/view/69/161Test; https://jkcvhl.com/index.php/jkcvhl/article/view/69/170Test; https://jkcvhl.com/index.php/jkcvhl/article/view/69Test
DOI: 10.15586/jkcvhl.2017.69
الإتاحة: https://doi.org/10.15586/jkcvhl.2017.69Test
https://jkcvhl.com/index.php/jkcvhl/article/view/69Test
حقوق: Copyright (c) 2017 pedro barata ; https://creativecommons.org/licenses/by-nc-nd/4.0Test
رقم الانضمام: edsbas.65B1E4C5
قاعدة البيانات: BASE